To better understand the role of these specific fibrinolytic markers in an acute myocardial infarction, we aimed to investigate the genetic expression, presence and localization of tPA, uPA, PAI-1 and PAI-2 in coronary thrombi from STEMI patients. This evidence concerns the gene SERPINB2 and myocardial infarction.